Rituximab combined with a TNF inhibitor and methotrexate shows no safety signal in RA treatment

Tuesday, March 8, 2011 - 10:30 in Health & Medicine

A recent trial of rituximab in combination with a tumor necrosis factor (TNF) inhibitor and methotrexate (MTX) in patients with active rheumatoid arthritis (RA) found the safety profile to be...

Read the whole article on Science Blog

More from Science Blog

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net